| Targeting IL-17B–IL-17RB signaling with an anti–IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines HH Wu, WW Hwang-Verslues, WH Lee, CK Huang, PC Wei, CL Chen, ... Journal of Experimental Medicine 212 (3), 333-349, 2015 | 145 | 2015 |
| Autocrine/paracrine mechanism of interleukin-17B receptor promotes breast tumorigenesis through NF-κB-mediated antiapoptotic pathway CK Huang, CY Yang, YM Jeng, CL Chen, HH Wu, YC Chang, C Ma, ... Oncogene 33 (23), 2968-2977, 2014 | 110 | 2014 |
| cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18 … HH Wu, JY Wu, YW Cheng, CY Chen, MC Lee, YG Goan, H Lee Clinical cancer research 16 (21), 5200-5210, 2010 | 84 | 2010 |
| Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-κB activation HH Wu, YW Cheng, JT Chang, TC Wu, WS Liu, CY Chen, H Lee Oncogene 29 (30), 4330-4340, 2010 | 52 | 2010 |
| Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer HH Wu, YC Chu, L Wang, LH Tsai, MC Lee, CY Chen, SH Shieh, ... Annals of surgical oncology 20, 336-347, 2013 | 33 | 2013 |
| Curcumin analogue L48H37 suppresses human osteosarcoma U2OS and MG-63 cells’ migration and invasion in culture by inhibition of uPA via the JAK/STAT signaling pathway KH Lu, HH Wu, RC Lin, YC Lin, PWA Lu, SF Yang, JS Yang Molecules 26 (1), 30, 2020 | 29 | 2020 |
| Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non–small cell lung cancer MC Tung, HH Wu, YW Cheng, L Wang, CY Chen, SD Yeh, TC Wu, H Lee Cancer 119 (18), 3367-3376, 2013 | 27 | 2013 |
| Clefma activates the extrinsic and intrinsic apoptotic processes through jnk1/2 and p38 pathways in human osteosarcoma cells JS Yang, RC Lin, YH Hsieh, HH Wu, GC Li, YC Lin, SF Yang, KH Lu Molecules 24 (18), 3280, 2019 | 18 | 2019 |
| An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium JN Tung, HH Wu, CC Chiang, YY Tsai, MC Chou, H Lee, YW Cheng Molecular Vision 16, 623, 2010 | 18 | 2010 |
| Characterization of initial key steps of IL-17 receptor B oncogenic signaling for targeted therapy of pancreatic cancer HH Wu, LH Tsai, CK Huang, PH Hsu, MY Chen, YI Chen, CM Hu, ... Science Translational Medicine 13 (583), eabc2823, 2021 | 14 | 2021 |
| Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach Y Qi, YL Lai, PC Shen, FH Chen, LJ Lin, HH Wu, PH Peng, KW Hsu, ... Scientific Reports 10 (1), 22270, 2020 | 14 | 2020 |
| Systematic identification of clinically relevant miRNAs for potential miRNA-based therapy in lung adenocarcinoma SH Liu, KW Hsu, YL Lai, YF Lin, FH Chen, PH Peng, LJ Lin, HH Wu, CY Li, ... Molecular Therapy-Nucleic Acids 25, 1-10, 2021 | 13 | 2021 |
| Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer LH Tsai, KW Hsu, CM Chiang, HJ Yang, YH Liu, SF Yang, PH Peng, ... Scientific reports 10 (1), 17817, 2020 | 10 | 2020 |
| Targeting interleukin-17 receptors WH Lee, HH Wu, CK Huang Oncotarget 6 (21), 18244, 2015 | 7 | 2015 |
| CLEFMA induces intrinsic and extrinsic apoptotic pathways through ERK1/2 and p38 signalling in uterine cervical cancer cells CY Lee, YH Hsiao, PN Chen, HH Wu, CY Lu, SF Yang, PH Wang Journal of Cellular and Molecular Medicine 27 (3), 446-455, 2023 | 5 | 2023 |
| Involvement of prohibitin 1 and prohibitin 2 upregulation in cBSA-induced podocyte cytotoxicity HH Wu, CJ Chen, PY Lin, YH Liu journal of food and drug analysis 28 (1), 183-194, 2020 | 3 | 2020 |
| RP11‐367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial–mesenchymal transition IH Shao, PH Peng, HH Wu, JL Chen, JCY Lai, JS Chang, HT Wu, KJ Wu, ... Cancer Medicine 12 (8), 9788-9801, 2023 | 1 | 2023 |
| Antagonist of interleukin-17b receptor (il-17rb) and use thereof WH Lee, HH Wu, CM Hu, CK Huang US Patent App. 18/266,882, 2024 | | 2024 |
| Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis PH Peng, JL Chen, HH Wu, WH Yang, LJ Lin, JCY Lai, JS Chang, JL Syu, ... Cancer Cell International 23 (1), 266, 2023 | | 2023 |
| Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapy WH Lee, JY Shew, C Ma, CL Chen, WH Lee, CK Huang, HH Wu US Patent 10,793,628, 2020 | | 2020 |
